Search Results - "Haglund C"

Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas.

Authors: Hedström, J. Haglund, C. Leinonen, J. et al.

Source: Scandinavian Journal of Clinical & Laboratory Investigation. Apr2001, Vol. 61 Issue 2, p111-118. 8p. 4 Black and White Photographs, 3 Charts, 3 Graphs.

In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues.

Authors: Haglund C Aleskog A Nygren P et al.

Source: Cancer Chemotherapy & Pharmacology. Mar2012, Vol. 69 Issue 3, p697-707. 11p.

Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivity

Authors: Hassan, S.B. Haglund, C. A˚leskog, A. et al.

Source: Toxicology in Vitro. Sep2007, Vol. 21 Issue 6, p1174-1181. 8p.

Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas.

Authors: Salmenkivi, K Heikkilä, P Haglund, C et al.

Source: Histopathology. Jul2003, Vol. 43 Issue 1, p62. 10p.

Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma.

Authors: Koljonen, V. Tukiainen, E. Haglund, C. et al.

Source: Histopathology. Nov2006, Vol. 49 Issue 5, p551-553. 3p. 1 Diagram, 1 Chart.

This result is not displayed to guests.
Login for full access.

Pulmonary endostatin perinatally and in lung injury of the newborn infant.

Authors: Janér J Andersson S Haglund C et al.

Source: Pediatrics. Jan2007, Vol. 119 Issue 1, pe241-6. 1p.

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.

Authors: Österroos, A. Kashif, M. Haglund, C. et al.

Source: Biochemical Pharmacology. Oct2016, Vol. 118, p40-49. 10p.

Successful Methods: Getting Good Service: A Two-Way Street: Service Is One Of Those Make It/Break It Aspects Of Meeting Planning.

Authors: Wohlecke-Haglund, C. (AUTHOR)

Source: Successful Meetings. Nov1986, Vol. 35 Issue 11, p167-167. 1p.

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use

Authors: Duffy, M.J. van Dalen, A. Haglund, C. et al.

Source: European Journal of Cancer. Jun2007, Vol. 43 Issue 9, p1348-1360. 13p.

When I go in to wake them ... I wonder: parental perceptions about congenital long QT syndrome.

Authors: Farnsworth MM Fosyth D Haglund C et al.

Source: Journal of the American Academy of Nurse Practitioners. Jun2006, Vol. 18 Issue 6, p284-290. 7p.

URL: 20888829

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines

Authors: Duffy, M.J. van Dalen, A. Haglund, C. et al.

Source: European Journal of Cancer. Apr2003, Vol. 39 Issue 6, p718. 10p.

Blueprint for panniers. Following these easy instructions could save you hard-earned cash when looking over the purchase of a new set of touring bags.

Authors: Haglund, C.

Source: Bike World. July/Aug, 1979: Vol. 8 Issue 4. p. 39-43-43.

Expression and prognostic value of transcription factor PROX1 in colorectal cancer.

Authors: Skog, M Bono, P Lundin, M et al.

Source: British Journal of Cancer. 10/25/2011, Vol. 105 Issue 9, p1346-1351. 6p. 1 Color Photograph, 3 Charts, 1 Graph.

Prognostic role of CIP2A expression in serous ovarian cancer.

Authors: Böckelman, C Lassus, H Hemmes, A et al.

Source: British Journal of Cancer. 9/27/2011, Vol. 105 Issue 7, p989-995. 7p. 1 Color Photograph, 1 Black and White Photograph, 2 Charts, 2 Graphs.

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer.

Authors: Böckelman, C. Hagström, J. Mäkinen, L. K. et al.

Source: British Journal of Cancer. 6/7/2011, Vol. 104 Issue 12, p1890-1895. 6p. 2 Color Photographs, 4 Charts, 1 Graph.

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.

Authors: Häyry, V. Mäkinen, L. K. Atula, T. et al.

Source: British Journal of Cancer. 3/2/2010, Vol. 102 Issue 5, p892-897. 6p. 2 Color Photographs, 1 Chart, 1 Graph.

Expression of the androgen receptor and syndecan-1 in breast tissue during different hormonal treatments in cynomolgus monkeys.

Authors: Hofling, M. Ma, L. Sahlin, L. et al.

Source: Climacteric. Feb2009, Vol. 12 Issue 1, p72-79. 8p. 1 Diagram, 1 Chart, 1 Graph.

Genome‐controlled reverse transcriptase‐polymerase chain reaction for targeted gene‐expression analysis.

Authors: Stenman, J. Räsänen, J. Tenkanen, T. et al.

Source: Scandinavian Journal of Clinical & Laboratory Investigation. Nov2006, Vol. 66 Issue 7, p597-606. 10p. 2 Diagrams, 2 Graphs.

High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.

Authors: Wiksten, J.-P. Lundin, J. Nordling, S. et al.

Source: Histopathology. Apr2005, Vol. 46 Issue 4, p380-388. 9p.